
Braveheart Bio jumps 68% in trading debut after $383M IPO
Braveheart Bio's IPO success highlights strong investor appetite for biotech innovation, despite risks of high valuations without revenue. The post Br...
Войдите в аккаунт.
Начните бесплатно.
5 articles · updated every 3 minutes

Braveheart Bio's IPO success highlights strong investor appetite for biotech innovation, despite risks of high valuations without revenue. The post Br...

The shift towards decentralized science models like Bio Protocol could democratize research funding, accelerating innovation and reducing bureaucracy....

OpenAI's enhanced bounty program underscores the growing importance of robust AI security measures, potentially setting industry standards. The post O...
In a Brazilian Congress hearing, Fábio Araújo, consultant for the Financial System Regulation Department (Denor), stressed that, unlike other crypto a...

AI-driven decentralization in biotech research could revolutionize scientific collaboration, enhancing efficiency and accountability in innovation. Th...